featured
Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical Trial
JAMA 2019 May 19;321(20)1993-2002, JL Vincent, B Francois, I Zabolotskikh, MK Daga, JB Lascarrou, MY Kirov, V Pettilä, X Wittebole, F Meziani, E Mercier, SM Lobo, PS Barie, M Crowther, CT Esmon, J Fareed, S Gando, KJ Gorelick, M Levi, JP Mira, SM Opal, J Parrillo, JA Russell, H Saito, K Tsuruta, T Sakai, D Fineberg, SCARLET Trial GroupFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.